Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

The study hypothesis is that liver transplantation after selective internal radiation therapy (SIRT) and chemotherapy would improve 3-year overall survival in patients with locally advanced (unresectable but non-metastatic) intrahepatic cholangiocarcinoma.

It is planned to include 36 patients with locally advanced intrahepatic cholangiocarcinoma, not eligible for initial surgery and without metastases. Participants will be recruited from care facilities in France.

Eligibility criteria

Qualifiers

Patient aged 18 to 65

Uni or pauci nodular (≤ 5 lesions (all lesions are counted, even those less than 1 cm))

Without extrahepatic or lymph node involvement

Technically unresectable R0 according to an expert panel

Disqualifiers

Extrahepatic, vesicular or perihilar cholangiocarcinoma

Tumor infiltration of more than 50% of the liver

Mixed cholangiocarcinoma, hepatocellular carcinoma, fibrolamellar carcinoma

Previous treatment for CCI

Trial design

Treatments tested in this trial

  • Liver transplant

Treatment groups

36 Participants
are divided into 1 treatment group